Picard Medical, Inc. (PMI)
2025-06-30 | |
|---|---|
| Total revenues-Products | 2,131,000 |
| Total cost of revenues | 2,258,000 |
| Total cost of revenues-Rentals | 707,000 |
| Total cost of revenues-Products | 1,551,000 |
| Total revenues-Rentals | - |
| Total revenues | 2,131,000 |
| Gross profit (loss) | -127,000 |
| Selling, general and administrative | 2,651,000 |
| Research and development | 743,000 |
| Total operating expenses | 3,394,000 |
| Operating loss | -3,521,000 |
| Interest expense | 2,427,000 |
| Derivative loss | 776,000 |
| Loss before income taxes | -6,724,000 |
| Provision for income taxes | - |
| Net loss | -6,724,000 |
| Undeclared series a-1 preferred dividends | -796,000 |
| Net loss attributable to common stockholders | -7,520,000 |
| Net loss | -6,724,000 |
| Foreign currency translation adjustments, net of tax | -15,000 |
| Comprehensive loss | -6,739,000 |